Article
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
PLoS computational biology - 1 Feb 2018
Sun James X, He Yuting, Sanford Eric, Montesion Meagan, Frampton Garrett M, Vignot Stéphane, Soria Jean-Charles, Ross Jeffrey S, Miller Vincent A, Stephens Phil J, Lipson Doron, Yelensky Roman
Abstract excerpt
A key constraint in genomic testing in oncology is that matched normal specimens are not commonly obtained in clinical practice. Thus, while well-characterized genomic alterations do not require normal tissue for interpretation, a significant number of alterations will be unknown in whether they are germline or somatic, in the absence of a matched normal control. We introduce SGZ (somatic-germline-zygosity), a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
